ASTM E2977-15

4.1 This practice permits an analyst to compare the performance of an NMR spectrometer for a particular test on any given day with the instrument's prior performance for that test. The practice can also provide sufficient quantitative performance information for problem diagnosis and solving. If complete information about how a test is carried out is supplied and sufficient replicates are collected to substantiate statistical relevance, the tests in this practice can be used to establish the setting and meeting of relevant performance specifications. This practice is not necessarily meant for the comparison of different instruments with each other, even if the instruments are of the same type and model. This practice is not meant for the comparison of the performance of different instruments operated under conditions differing from those specified for a particular test.

1.1 This practice covers procedures for measuring and reporting the performance of Fourier-transform nuclear magnetic resonance spectrometers (FT-NMRs) using liquid samples.

1.2 This practice is not directly applicable to FT-NMR spectrometers outfitted to measure gaseous, anisotropically structured liquid, semi-solid, or solid samples; those set up to work with flowing sample streams; or those used to make hyperpolarization measurements.

1.3 This practice was expressly developed for FT-NMR spectrometers operating with proton resonance frequencies between 200 and 1200 MHz.

1.4 This practice is not directly applicable to continuous wave (scanning) NMR spectrometers.

1.5 This practice is not directly applicable to instruments using single-sideband detection.

1.6 Units—The values stated in SI units are to be regarded as the standard. No other units of measurement are included in this standard.

1.7 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.